In this regard, Wnt5a was also found to modulate cell cycle progression and contributes to the chemoresistance in pancreatic cancer cells [70] and regulates ABCB1 expression in multidrug-resistant breast cancer cells through activation of the noncanonical PKA/beta-catenin pathway [48]. This evidence concerns the gene WNT5A and familial pancreatic carcinoma.